Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 12, Status: Authorised

Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions

Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Tasmar, tolcapone, Date of authorisation: 27/08/1997, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 33, Status: Authorised

Minutes of the PRAC meeting 7-10 July 2025

PSUSA/00010987/202501

PSUSA/00001418/202501

Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions - tracked changes